CSIMarket



Pfizer Inc  (PFE)
Other Ticker:  
 
 

PFE's Revenue Growth by Quarter and Year

Pfizer Inc's Revenue results by quarter and year




PFE Revenue (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter January - 23,635.00 11,684.00 12,688.00
III Quarter October - 24,094.00 12,131.00 12,680.00
II Quarter July - 18,977.00 11,801.00 13,264.00
I Quarter April 25,661.00 14,582.00 12,028.00 13,118.00
FY   25,661.00 81,288.00 47,644.00 51,750.00



PFE Revenue first quarter 2022 Y/Y Growth Comment
Pfizer Inc achieved in the first quarter 2022, above Company average Revenue rise of 75.98% year on year, to $ 25,661.00 millions.

Looking into first quarter 2022 results within Major Pharmaceutical Preparations industry 36 other companies have achieved higher Revenue growth. While Pfizer Inc' s Revenue jump of 75.98% ranks overall at the positon no. 335 in the first quarter 2022.




PFE Revenue ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter January - 102.29 % -7.91 % -9.22 %
III Quarter October - 98.62 % -4.33 % -4.65 %
II Quarter July - 60.81 % -11.03 % -1.5 %
I Quarter April 75.98 % 21.23 % -8.31 % 1.64 %
FY   - 70.62 % -7.93 % -3.54 %

Financial Statements
Pfizer Inc's first quarter 2022 Revenue $ 25,661.00 millions PFE's Income Statement
Pfizer Inc's first quarter 2021 Revenue $ 14,582.00 millions Quarterly PFE's Income Statement
New: More PFE's historic Revenue Growth >>


PFE Revenue (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter January - -1.91 % -3.68 % 0.06 %
III Quarter October - 26.96 % 2.8 % -4.4 %
II Quarter July - 30.14 % -1.89 % 1.11 %
I Quarter April 8.57 % 24.8 % -5.2 % -6.15 %
FY (Year on Year)   - 70.62 % -7.93 % -3.54 %




Revenue first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #37
Healthcare Sector #81
Overall #335

Revenue Y/Y Growth Statistics
High Average Low
68.78 % 1.12 % -51.77 %
(Dec 31 2013)   (Sep. 30, 2015)
Revenue first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #37
Healthcare Sector #81
Overall #335
Revenue Y/Y Growth Statistics
High Average Low
68.78 % 1.12 % -51.77 %
(Dec 31 2013)   (Sep. 30, 2015)

Revenue by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Pfizer Inc's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
42.3 % 1.4 % -17.64 %
(Dec. 30. 2009)  


PFE's I. Quarter Q/Q Revenue Comment
Pfizer Inc achieved in the I. Quarter 2022 above company average sequential Revenue increase of 8.57%, to $ 25,661.00 millions, from $23,635.00 millions in the forth quarter.

Within Major Pharmaceutical Preparations industry 61 other companies have achieved higher Revenue quarter on quarter growth. While Pfizer Inc's Revenue growth quarter on quarter, overall rank is 745.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #62
Healthcare Sector #146
Overall #745
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #62
Healthcare Sector #146
Overall #745
Revenue Q/Q Growth Statistics
High Average Low
42.3 % 1.4 % -17.64 %
(Dec. 30. 2009)  


PFE's I. Quarter Q/Q Revenue Comment
Pfizer Inc achieved in the I. Quarter 2022 above company average sequential Revenue increase of 8.57%, to $ 25,661.00 millions, from $23,635.00 millions in the forth quarter.

Within Major Pharmaceutical Preparations industry 61 other companies have achieved higher Revenue quarter on quarter growth. While Pfizer Inc's Revenue growth quarter on quarter, overall rank is 745.


Pfizer Inc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Apr 03 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Oct 03 2021)
12 Months Ending
(Jul 04 2021)
12 Months Ending
(Apr 04 2021)
Cumulative Revenue 12 Months Ending $ 92,367.00 $ 81,288.00 $ 69,337.00 $ 57,374.00 $ 50,198.00
Y / Y Revenue Growth (TTM) 84.01 % 70.62 % 42.53 % 16.62 % -0.91 %
Year on Year Revenue Growth Overall Ranking # 301 # 513 # 706 # 1392 # 2082
Seqeuential Revenue Change (TTM) 13.63 % 17.24 % 20.85 % 14.3 % 5.36 %
Seq. Revenue Growth (TTM) Overall Ranking # 335 # 745 # 405 # 406 # 786




Cumulative Revenue growth Comment
With 84.01% annual Revenue growth, Pfizer Inc would report a record annual Revenue growth if the fiscal year would end on Apr 03 2022.

In the Healthcare sector 62 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 301, from total ranking in previous quarter at 513.

Revenue TTM Q/Q Growth Statistics
High Average Low
68.78 %
1.12 %
-51.77 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 37
Healthcare Sector # 63
Overall # 301

Revenue TTM Y/Y Growth Statistics
High Average Low
84.01 %
4.34 %
-19.02 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 37
Sector # 81
S&P 500 # 335
Cumulative Revenue growth Comment
With 84.01% annual Revenue growth, Pfizer Inc would report a record annual Revenue growth if the fiscal year would end on Apr 03 2022.

In the Healthcare sector 62 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 301, from total ranking in previous quarter at 513.

Revenue TTM Q/Q Growth Statistics
High Average Low
68.78 %
1.12 %
-51.77 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 37
Healthcare Sector # 63
Overall # 301

Revenue TTM Y/Y Growth Statistics
High Average Low
84.01 %
4.34 %
-19.02 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 37
Sector # 81
S&P 500 # 335




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
PFE's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for PFE's Competitors
Revenue Growth for Pfizer Inc's Suppliers
Revenue Growth for PFE's Customers

You may also want to know
PFE's Annual Growth Rates PFE's Profitability Ratios PFE's Asset Turnover Ratio PFE's Dividend Growth
PFE's Roe PFE's Valuation Ratios PFE's Financial Strength Ratios PFE's Dividend Payout Ratio
PFE's Roa PFE's Inventory Turnover Ratio PFE's Growth Rates PFE's Dividend Comparisons



Companies with similar Revenue growth for the quarter ending Apr 03 2022 within Healthcare SectorY/Y Change %Revenue for the quarter ending Apr 03 2022
Pfizer Inc75.98%$ 75.977 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

HYAS's Profile

Stock Price

HYAS's Financials

Business Description

Fundamentals

Charts & Quotes

HYAS's News

Suppliers

HYAS's Competitors

Customers & Markets

Economic Indicators

HYAS's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071